PHARYNDOL-KIDS : Treatment for throat infection (pharyngitis)

Overview

Vitrobio presents Pharyndol Kids, a specialized solution designed for the treatment of viral or bacterial throat infections, such as pharyngitis, in children. This product is a throat spray in a convenient 20 ml format, designed for easy application and optimal delivery of the active components.

Mode of Action 

Vitrobio’s throat treatment products work through a unique three-step process to provide relief from throat discomfort and promote healing.

Protective Barrier: The first step involves the creation of a protective barrier on the throat’s mucous membrane. This is achieved through the use of filmogenic glycerol, which not only acts as a shield against external contaminants but also provides hydration and soothes the irritated throat. This protective barrier is crucial in preventing further irritation and providing immediate relief.

Mechanical Cleaning: The second step is mechanical cleaning, which is facilitated by the product’s high osmotic activity. This osmotic action instantly attracts and traps most of the adhered contaminants, including inflammatory proteins, bacteria, and viruses. By removing these harmful substances, the product effectively suppresses inflammation and halts the immune cascade, leading to a reduction in throat discomfort.

Cellular Repair: The final step is cellular repair. Once the throat’s biological surface is clean and hydrated, cell growth and healing are immediately triggered. This promotes the repair and regeneration of the throat’s mucous membrane, leading to long-term relief and recovery.

Clinical Trial Results

The effectiveness of Pharyndol Kids has been evaluated in a randomized, double-blind, placebo-controlled trial conducted over 15 days with 30 patients. The trial included children with recent symptoms of a throat infection.

The main results of the trial were highly promising. There was a 15% improvement in swallowing within 2 hours and a 51% improvement within 3 days of application. Throat irritation and redness were also significantly reduced, with a 47.32% reduction and a 56.3% reduction respectively within 3 days. Importantly, no side effects were recorded during the trial, demonstrating the safety of Pharyndol Kids.

See full publication (PDF)

Main results

15 % improvement in swallowing within 2 hours.
51 % improvement in swallowing within 3 days
47,32 % reduction in throat irritation within 3 days.
56,3 % reduction in throat redness within 3 days.
No side effects recorded​

In conclusion, Pharyndol Kids represents a significant advancement in the treatment of viral or bacterial throat infections in children. Its unique mechanism of action, combined with its ease of use and rapid results, make it a promising addition to the therapeutic options available for these common conditions.